Skip to main content
Open
Question
Forecasts
Track record
Unknowns
How it works
Sources
FAQ
Menu
← Evidence map
Article
Pharmacogenomics
2012
EGFR R521K predicts cetuximab response in KRAS wild-type patients.
Sharon Marsh
PubMed ↗
No numbers read from the abstract.
Not cited yet
EGFR R521K predicts cetuximab response in KRAS wild-type patients. | OpenQuestion